Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Moulded tie strips
Systems and methods for parameter adaptation
Agglutination judgment method
Variety corn line NPAA2675
Methods and systems for sending messages regarding an emergency that occurred at a facility
Veronica plant named `Amethyst Plume`
Nonvolatile semiconductor memory device
  Randomly Featured Patents
Shock-absorbing system for pulsed nuclear power plant
Customer premise equipment interface
Positive resists containing dimethylglutarimide units
Method and apparatus for actuating fuel trim valves in a gas turbine
Attachment fixture for the front panel and grill of a speaker assembly
Wellbore treatment apparatus and method
Under bump metallurgy for lead-tin bump over copper pad
Process for producing ethylene-.alpha.-olefin copolymers
Reducing agent container having an improved structure
Crystalline colloidal narrow band radiation filter